This afternoon we watched Option Care Health rise 1.4% to a price of $28.77 per share. The mid-cap Medical Care Facility company is now trading -24.94% below its average target price of $38.33. Analysts have set target prices ranging from $37 to $40 per share for Option Care Health, and have given the stock an average rating of buy.
The stock has an average amount of shares sold short at 4.4%, and a short ratio of 5.64. Since 14.69% of the company's shares are owned by insiders, we can infer that there is a degree of alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 83.1% of Option Care Health's shares being owned by this investor type.
Institutions Invested in Option Care Health
| Holder | Shares | Date Reported | Percentage | Value |
|---|---|---|---|---|
| FMR, LLC | 19,738,359 | 2022-06-29 | 11% | $548,528,996 |
| Blackrock Inc. | 15,897,128 | 2022-06-29 | 9% | $441,781,187 |
| Vanguard Group, Inc. (The) | 14,121,852 | 2022-06-29 | 8% | $392,446,267 |
| Price (T.Rowe) Associates Inc | 9,389,438 | 2022-06-29 | 5% | $260,932,482 |
| Park West Asset Management LLC | 4,827,679 | 2022-06-29 | 3% | $134,161,199 |
| State Street Corporation | 4,476,389 | 2022-06-29 | 2% | $124,398,850 |
| Ubs Asset Management Americas Inc | 3,964,086 | 2022-06-29 | 2% | $110,161,949 |
| Marshall Wace LLP | 3,933,573 | 2022-06-29 | 2% | $109,313,993 |
| Bellevue Group AG | 2,887,259 | 2022-06-29 | 2% | $80,236,927 |
| Nuveen Asset Management | 2,700,290 | 2022-06-29 | 1% | $75,041,059 |
Besides an analyst consensus of strong upside potential, other market factors point to there being positive market sentiment on Option Care Health.
